NewswireJet

EPR-Technologies, Inc., a Leading Biomedical Company, Raises 26K Since its Equity Crowdfunding Campaign started

EPR-Technologies, Inc. (the “Company”) is a privately held Arizona corporation (incorporated June 13, 2006) that was formed to utilize the patent of the method developed at the Safar Center for Resuscitation Research, University of Pittsburgh School of Medicine (the “Safar Center”), as well as specialized technology products developed by the Company exclusively. The Company is a biotechnology spinoff of the Safar Center and is committed to the preservation of human life through advancements in emergency medical resuscitation. EPR-Technologies utilizes the revolutionary emergency resuscitation capabilities developed by the Safar Center over the past two decades to form the basis of its technology and “know-how” for a Company patented product line to support novel, advanced, life-saving emergency resuscitation by introducing products and procedures for “Emergency Preservation and Resuscitation” (EPR) to save a life when standard cardiopulmonary resuscitation (CPR) fails.

Washington D.C., Metropolitan Area, United States, October 28, 2022 – During their second equity crowdfunding campaign on Start Engine, EPR-Technologies has raised over $26,000 so far. EPR-Technologies intends to raise funds to establish EPR techniques as the new “Standard of Care” for emergency medicine when cardiopulmonary resuscitation (CPR) fails. 


As the industry leader seeking to bring EPR to market, EPR-Technologies is setting new standards in healthcare. Level I trauma hospitals, Level II through Level V hospitals, emergency rooms, intensive care units, patient floors, ambulances, and military combat casualty care facilities will all be served by EPR-Technologies products and services. Ultimately, adopting these exciting new EPR profound hypothermia technologies will extend Emergency Medicine investments in cooling equipment beyond that related just to mild hypothermia treatments to the EPR applications for profound hypothermia, keeping the therapeutic hypothermia and temperature management markets growing rapidly.  


In EPR, the patient is preserved for three hours or more, allowing time for critical surgical repairs or transport to a medical facility for medical/surgical interventions, followed by delayed resuscitation. Over the past two decades, the Safar Center for Resuscitation Research, University of Pittsburgh, has developed revolutionary emergency resuscitation capabilities that EPR-Technologies use to support novel, advanced, lifesaving emergency resuscitations by introducing soon-to-be patented products and procedures for EPR to save lives when standard CPR fails.


Investment into EPR-Technologies is currently open through Start Engine. Visit their Start Engine page for more information about EPR-Technologies and their equity crowdfunding campaign www.startengine.com/epr-technologies. Connect with EPR-Technologies on Facebook, Instagram, LinkedIn, and Twitter.

Media Contact
Company Name: EPR-Technologies, Inc.
Contact Person:  Lyn Yaffe
Phone:  (301) 467-2838
Website: https://eprtechnologiesllc.carrd.co/
Address: 23041 Wild Hunt Drive, Gaithersburg, MD 20882
City: Washington D.C. Metropolitan Area
Email: lyaffe@epr-technologies.com
Country: United States

Contact

Email

Send